T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Jazz Pharmaceuticals
JAZZ
$16B
| $4.7M | ﹤0.01% |
38,184
+1,041
| +3% | +$123K |
|
1302
Vail Resorts
MTN
$5.29B
| $4.66M | ﹤0.01% |
24,878
-2,746
| -10% | -$491K |
|
1303
Prime Medicine
PRME
$580M
| $4.63M | ﹤0.01% |
1,584,476
+38,515
| +2% | +$135K |
|
|
CHX
1304
DELISTED
ChampionX
CHX
| $4.62M | ﹤0.01% |
170,018
+9,529
| +6% | +$283K |
|
1305
Scorpio Tankers
STNG
$3.81B
| $4.61M | ﹤0.01% |
92,820
+10,016
| +12% | +$571K |
|
1306
OFG Bancorp
OFG
$2.26B
| $4.61M | ﹤0.01% |
108,845
-60,564
| -36% | -$2.61M |
|
1307
Aura Biosciences
AURA
$802M
| $4.58M | ﹤0.01% |
556,941
+40,815
| +8% | +$384K |
|
1308
Ryman Hospitality Properties
RHP
$7.82B
| $4.58M | ﹤0.01% |
43,873
+3,993
| +10% | +$444K |
|
1309
Prosperity Bancshares
PB
$8.95B
| $4.53M | ﹤0.01% |
60,113
+4,339
| +8% | +$335K |
|
|
JBTM
1310
JBT Marel
JBTM
$6.15B
| $4.51M | ﹤0.01% |
35,472
+8,242
| +30% | +$951K |
|
1311
Dolby
DLB
$5.84B
| $4.51M | ﹤0.01% |
57,694
-137,921
| -71% | -$10.5M |
|
1312
Kemper
KMPR
$1.56B
| $4.5M | ﹤0.01% |
67,686
-42,667
| -39% | -$2.81M |
|
1313
AGNC Investment
AGNC
$13B
| $4.48M | ﹤0.01% |
486,010
+66,289
| +16% | +$647K |
|
1314
KB Home
KBH
$3.42B
| $4.45M | ﹤0.01% |
67,758
+16,576
| +32% | +$1.29M |
|
|
CADE
1315
DELISTED
Cadence Bank
CADE
| $4.44M | ﹤0.01% |
128,885
+12,427
| +11% | +$437K |
|
1316
First American
FAF
$7.56B
| $4.44M | ﹤0.01% |
71,036
-6,691
| -9% | -$436K |
|
1317
Lyell Immunopharma
LYEL
$347M
| $4.42M | ﹤0.01% |
345,537
-22,077
| -6% | -$438K |
|
1318
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $4.37M | ﹤0.01% |
104,700
| – | – |
|
1319
Chord Energy
CHRD
$7.35B
| $4.33M | ﹤0.01% |
37,071
+3,359
| +10% | +$422K |
|
1320
Alarm.com
ALRM
$2.72B
| $4.33M | ﹤0.01% |
71,133
+3,530
| +5% | +$210K |
|
1321
Lumen
LUMN
$6.6B
| $4.3M | ﹤0.01% |
809,269
+65,168
| +9% | +$450K |
|
1322
Idacorp
IDA
$8.21B
| $4.29M | ﹤0.01% |
39,230
-16,488
| -30% | -$1.81M |
|
1323
Cal-Maine
CALM
$3.87B
| $4.28M | ﹤0.01% |
41,592
+10,972
| +36% | +$1.04M |
|
1324
Snap
SNAP
$8.96B
| $4.28M | ﹤0.01% |
397,526
-61,164
| -13% | -$690K |
|
1325
Argan
AGX
$8.02B
| $4.26M | ﹤0.01% |
31,078
+4,341
| +16% | +$596K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.